Concepedia

Publication | Open Access

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

1.5K

Citations

25

References

2011

Year

Abstract

Vandetanib demonstrated therapeutic efficacy in a phase III trial of patients with advanced MTC (ClinicalTrials.gov NCT00410761).

References

YearCitations

Page 1